| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01784536 | Healthy | Drug: Single-Dose IV Oritavancin Diphosphate | The Medicines Company | Phase 1 | 2013-01-01 | 2013-04-16 |
| NCT02340988 | Healthy | Drug: Single-Dose IV Oritavancin Diphosphate and Warfarin|Drug: Single-Dose IV Oritavancin Diphosphate and Warfarin 24 hour post dose | The Medicines Company | Phase 1 | 2015-04-01 | 2015-11-02 |
| NCT01762839 | Healthy | Drug: Single-Dose IV Oritavancin Diphosphate|Drug: Placebo|Drug: Moxifloxacin | The Medicines Company | Phase 1 | 2013-01-01 | 2013-04-16 |
| NCT01252719 | Wound Infection|Abscess|Systemic Inflammation|Cellulitis | Drug: Single-Dose IV Oritavancin Diphosphate|Drug: IV Vancomycin | The Medicines Company | Phase 3 | 2010-12-01 | 2012-11-09 |
| NCT01252732 | Wound Infection|Abscess|Systemic Inflammation|Cellulitis | Drug: Single-Dose IV Oritavancin Diphosphate|Drug: IV Vancomycin | The Medicines Company | Phase 3 | 2010-12-01 | 2013-06-25 |
| NCT02134301 | Gram Positive Bacterial Infections | Drug: Oritavancin | The Medicines Company | Phase 1 | 2014-05-01 | 2015-11-04 |
